same active ingredient as Ozempic and Wegovy, but not FDA-approved Brand-Name Options (for eligible patients): Wegovy (semaglutide, FDA-approved for weight loss), Ozempic (semaglutide, off-label for weight loss), Zepbound and Mounjaro (tirzepatide), generic liraglutide (daily injection) Oral Medication Kits (non-injectable): Personalized oral combinations of naltrexone + bupropion, with options to add metformin or topiramate from $69/month as a 10-month prepaid plan App and Support Features: Access to the Hers app, including dynamic protocols to help improve nutrition, movement, and sleep-based habits for sustained weight loss Prescription anti-nausea medication (ondansetron) is included for eligible patients on GLP-1 injections at no extra cost 24/7 provider messaging access included Hers reports that on average, customers lost 11.1 lbs with compounded GLP-1 injections and 7.9 lbs with oral medication kits in the first two months of treatment alongside a reduced-calorie diet and exercise

Mechanistic Links Between GLP-1 RAs and Thyroid Neoplasms GLP-1 receptor effects on thyroid tissue originate from GLP-1 receptors present on thyroid cells
To view a copy of this licence, visit About this article Cite this article Zhang, L., Chen, X., Xu, Y
doi: 10.1080/13548506.2023.2195670 24 RavindranMAdewuyiOZhengYRayhanRULeUTimbolCet al